We are live on
!
Find out more
NFC
Northeast Financial Consultants Portfolio holdings
AUM
$2.45B
1-Year Est. Return
15.14%
This Fund
S&P 500
This Quarter
Est. Return
+2.18%
1 Year Est. Return
+15.14%
3 Year Est. Return
+63.77%
5 Year Est. Return
+108.46%
10 Year Est. Return
+198.58%
AUM
$254M
AUM Growth
+$14.3M
(+6%)
Cap. Flow
+$11.4M
Cap. Flow
% of AUM
4.51%
Top 10 Holdings %
Top 10 Hldgs %
51.18%
Holding
152
New
3
Increased
33
Reduced
31
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard International High Dividend Yield ETF
VYMI
|
+$6.16M |
| 2 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$3.5M |
| 3 |
Vanguard Growth ETF
VUG
|
+$1.59M |
| 4 |
ETP
Energy Transfer Partners L.p.
ETP
|
+$1.38M |
| 5 |
SLY
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
|
+$1.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.18M |
| 2 |
ExxonMobil
XOM
|
+$1.1M |
| 3 |
Vanguard Real Estate ETF
VNQ
|
+$883K |
| 4 |
Kinder Morgan
KMI
|
+$674K |
| 5 |
International Flavors & Fragrances
IFF
|
+$515K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.84% |
| 2 | Energy | 8.13% |
| 3 | Financials | 4.88% |
| 4 | Communication Services | 4.83% |
| 5 | Technology | 3.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Pfizer
PFE
$140B
| $47.9M | 18.87% |
1,502,782
-69,036
| -4% | -$2.18M |
|
|
2
Vanguard Growth ETF
VUG
$216B
| $22M | 8.65% |
1,036,992
+75,852
| +8% | +$1.59M |
|
3
Vanguard High Dividend Yield ETF
VYM
$81.1B
| $17.8M | 7.03% |
228,371
+9,613
| +4% | +$749K |
|
4
Vanguard Total Stock Market ETF
VTI
$654B
| $8.48M | 3.34% |
68,138
+463
| +0.7% | +$57.1K |
|
|
5
Vanguard International High Dividend Yield ETF
VYMI
$20.2B
| $6.68M | 2.63% |
106,806
+99,109
| +1,288% | +$6.16M |
|
6
Chevron
CVX
$388B
| $6.17M | 2.43% |
59,150
-1,124
| -2% | -$119K |
|
|
SLY
7
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
| $5.65M | 2.23% |
91,696
+18,126
| +25% | +$1.1M |
|
8
Amazon
AMZN
$2.5T
| $5.33M | 2.1% |
110,080
+700
| +0.6% | +$33.4K |
|
|
9
First Trust Dow Jones Internet Index Fund ETF
FDN
$4.86B
| $5.2M | 2.05% |
54,917
+37,663
| +218% | +$3.5M |
|
10
MetLife
MET
$61B
| $4.67M | 1.84% |
95,352
-1,234
| -1% | -$57.2K |
|
11
Invesco QQQ Trust
QQQ
$455B
| $4.42M | 1.74% |
32,103
-21
| -0.1% | -$2.89K |
|
12
Alphabet (Google) Class C
GOOG
$3.9T
| $4.1M | 1.62% |
90,260
-700
| -0.8% | -$32K |
|
|
13
Alphabet (Google) Class A
GOOGL
$3.91T
| $4.07M | 1.61% |
87,620
+340
| +0.4% | +$15.9K |
|
14
Enterprise Products Partners
EPD
$83.8B
| $3.92M | 1.54% |
144,680
+11,400
| +9% | +$309K |
|
15
Vanguard Financials ETF
VFH
$13.3B
| $3.9M | 1.54% |
62,301
+16,261
| +35% | +$982K |
|
16
Vanguard Small-Cap Value ETF
VBR
$37.1B
| $3.83M | 1.51% |
31,185
| – | – |
|
17
WisdomTree US MidCap Fund
EZM
$937M
| $3.61M | 1.42% |
100,950
-3,300
| -3% | -$117K |
|
18
Vertex Pharmaceuticals
VRTX
$121B
| $3.09M | 1.22% |
23,971
| – | – |
|
|
19
International Flavors & Fragrances
IFF
$19.4B
| $3.01M | 1.19% |
22,305
-3,800
| -15% | -$515K |
|
20
Johnson & Johnson
JNJ
$635B
| $2.99M | 1.18% |
22,600
-156
| -0.7% | -$19.9K |
|
|
AST
21
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
| $2.6M | 1.02% |
732,265
| – | – |
|
22
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $2.41M | 0.95% |
9,967
+3,116
| +45% | +$747K |
|
|
HDV
23
iShares Core High Dividend ETF
HDV
$14.4B
| $2.32M | 0.91% |
139,430
+5,180
| +4% | +$86.9K |
|
24
Vanguard S&P 500 ETF
VOO
$968B
| $2.2M | 0.87% |
9,888
+71
| +0.7% | +$15.6K |
|
25
Invesco S&P 500 Equal Weight Industrials ETF
RSPN
$1.1B
| $2.18M | 0.86% |
100,785
+34,285
| +52% | +$724K |
|
Similar funds
MC
WBA
MD
GL
SVCF
GLA
HIP
MME
Northeast Financial Consultants's Q2 2017 Portfolio in Review
As of Q2 2017, Northeast Financial Consultants held 152 positions worth $254M, up 6% from $239M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Northeast Financial Consultants deployed $11.4M of net new capital in Q2 2017, opening 3 new positions and adding to 33 existing holdings. Its largest new stake was Alibaba: 1,800 shares worth $254K.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Energy and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $2.18M trimmed.
- Northeast Financial Consultants's largest Q2 2017 buy was Alibaba: 1,800 shares worth $254K.
- Northeast Financial Consultants added most to Vanguard International High Dividend Yield ETF in Q2 2017, an estimated $6.16M increase.
- Northeast Financial Consultants's biggest Q2 2017 reduction was Pfizer, cutting an estimated $2.18M.
- Northeast Financial Consultants fully exited Energy Transfer Partners, L.P. in Q2 2017, selling an estimated $484K.
- Northeast Financial Consultants's ten largest holdings make up 51% of its $254M portfolio in Q2 2017.
- Northeast Financial Consultants opened 3 new positions and closed 10 in Q2 2017.
- Northeast Financial Consultants's portfolio value rose 6% quarter-over-quarter to $254M.
Based on Northeast Financial Consultants's 13F filing for Q2 2017, filed 26 Jul 2017.